UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported): September 9,
2009
MEDASORB
TECHNOLOGIES CORPORATION
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-51038
|
|
98-0373793
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification Number)
|
7
Deer Park Drive, Suite K
Monmouth
Junction, New Jersey 08852
(Address
of principal executive office) (Zip Code)
(732)
329-8885
Registrant’s
telephone number, including area code:
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.below):
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13c-4(c))
|
Item
7.01 Regulation FD Disclosure.
Officers
of Medasorb Technologies Corporation (the “Company”) expect to participate in
information sessions with analysts and investors during Rodman & Renshaw
Investor Conference (the “Rodman Conference”), being held during the second week
of September 2009. A copy of the presentation materials to be made available at
the Rodman Conference and at any one-on-one investor meetings is being furnished
as Exhibit 99.1 hereto.
The
information in this Form 8-K (including Exhibit 99.1) shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the
“Exchange Act”) or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933 or the Exchange Act, except as expressly set forth by specific
reference in such a filing.
Item
9.01 Financial Statement and Exhibits.
(a)
|
Financial
Statements of Business Acquired.
|
|
Not
applicable.
|
|
|
(b)
|
Pro
Forma Financial Information.
|
|
Not
applicable.
|
|
|
(c)
|
Shell
company transactions.
|
|
None.
|
|
|
(d)
|
Exhibits.
|
99.1
|
Slide presentation presented at
the Rodman &
Renshaw Investor
Conference on September 9, 2009. The slide presentation is furnished
and not filed pursuant to Instruction B.2 of
Form 8-K.
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Medasorb
Technologies Corporation
|
|
|
|
|
|
|
|
|
By:
|
/s/ David
Lamadrid
|
|
|
|
Name:
David Lamadrid
|
|
|
|
Title:
Chief Financial Officer
|
|
Dated:
September 15, 2009